Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Pediatric onco-nephrology: time to spread the word
by
Nada, Arwa
, Jetton, Jennifer G
in
CD19 antigen
/ Children
/ Chimeric antigen receptors
/ Kidney diseases
/ Lymphocytes T
/ Malignancy
/ Nephrology
/ Pediatrics
2021
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Pediatric onco-nephrology: time to spread the word
by
Nada, Arwa
, Jetton, Jennifer G
in
CD19 antigen
/ Children
/ Chimeric antigen receptors
/ Kidney diseases
/ Lymphocytes T
/ Malignancy
/ Nephrology
/ Pediatrics
2021
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Pediatric onco-nephrology: time to spread the word
2021
Request Book From Autostore
and Choose the Collection Method
Overview
Onco-nephrology has been a growing field within the adult nephrology scope of practice. Even though pediatric nephrologists have been increasingly involved in the care of children with different forms of malignancy, there has not been an emphasis on developing special expertise in this area. The fast pace of discovery in this field, including the development of new therapy protocols with their own kidney side effects and the introduction of the CD19-targeted chimeric antigen receptor T cell (CAR-T) therapy, has introduced new challenges for general pediatric nephrologists because of the unique effects of these treatments on the kidney. Moreover, with the improved outcomes in children receiving cancer therapy come an increased number of survivors at risk for chronic kidney disease related to both their cancer diagnosis and therapy. Therefore, it is time for pediatric onco-nephrology to take its spot on the expanding subspecialties map in pediatric nephrology.
Publisher
Springer Nature B.V
Subject
This website uses cookies to ensure you get the best experience on our website.